Roswell Park’s Center for Immunotherapy is equipped for every stage of developing novel immunotherapies, from discovery to clinical trials, all in one location. Few institutions in the U.S. have this capability. The center comprises three core facilities:
- The cGMP Therapeutic Cell Production Facility (TCPF)
- The Immune Analysis Facility (IAF)
- The Vector Development and Production Facility (VDPF)
The center maintains strong collaborative relationships with both academic institutions and private industry. It is supported by and works cooperatively with numerous Roswell Park departments, including Pathology, Biostatistics, Bioinformatics, and Technology Transfer. The Center for Immunotherapy initiates and supports multiple clinical trials at any given time, with additional trials in the pipeline.